UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$60
-30.2%
35,7140.0%0.02%
-36.1%
Q1 2024$86
+56.4%
35,7140.0%0.04%
+56.5%
Q4 2023$55
+41.0%
35,7140.0%0.02%
+35.3%
Q3 2023$39
-52.4%
35,7140.0%0.02%
-46.9%
Q2 2023$82
-5.7%
35,7140.0%0.03%
-3.0%
Q1 2023$87
+27.9%
35,7140.0%0.03%
+26.9%
Q4 2022$68
-99.9%
35,7140.0%0.03%
-18.8%
Q3 2022$86,000
+30.3%
35,7140.0%0.03%
+10.3%
Q2 2022$66,000
-12.0%
35,7140.0%0.03%
-25.6%
Q1 2022$75,000
-46.8%
35,7140.0%0.04%
-39.1%
Q4 2021$141,000
-18.0%
35,7140.0%0.06%
-34.7%
Q3 2021$172,000
+4.9%
35,7140.0%0.10%
-22.2%
Q2 2021$164,000
-21.9%
35,7140.0%0.13%
+2.4%
Q1 2021$210,000
+72.1%
35,7140.0%0.12%
-6.8%
Q4 2020$122,000
+139.2%
35,7140.0%0.13%
+149.1%
Q3 2020$51,000
-28.2%
35,7140.0%0.05%
-80.7%
Q2 2020$71,000
+1.4%
35,7140.0%0.28%
+183.5%
Q1 2020$70,000
-52.7%
35,7140.0%0.10%
-38.6%
Q4 2019$148,000
-34.2%
35,7140.0%0.16%
-43.4%
Q2 2019$225,000
+13.1%
35,7140.0%0.28%
+10.3%
Q1 2019$199,000
-16.0%
35,7140.0%0.25%
-1.2%
Q4 2018$237,000
-37.8%
35,7140.0%0.26%
-45.6%
Q3 2018$381,000
-11.2%
35,7140.0%0.47%
+185.5%
Q2 2018$429,000
+40.2%
35,7140.0%0.16%
+36.4%
Q1 2018$306,000
-13.3%
35,7140.0%0.12%
-91.1%
Q4 2017$353,000
-19.6%
35,7140.0%1.36%
+29.6%
Q3 2017$439,000
-25.2%
35,7140.0%1.05%
-39.7%
Q2 2017$587,000
+14.6%
35,7140.0%1.74%
+30.5%
Q1 2017$512,000
+3.6%
35,7140.0%1.34%
-5.6%
Q4 2016$494,000
-23.4%
35,7140.0%1.42%
-17.6%
Q3 2016$645,000
+26.0%
35,7140.0%1.72%
+15.6%
Q2 2016$512,000
+19.9%
35,7140.0%1.49%
+11.7%
Q1 2016$427,000
-10.1%
35,7140.0%1.33%
+36.2%
Q4 2015$475,000
+23.7%
35,7140.0%0.98%
+416.9%
Q3 2015$384,000
+33.8%
35,7140.0%0.19%
+83.5%
Q2 2015$287,00035,7140.10%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$46,410,00099.99%
Artal Group S.A. 57,517,978$617,743,00013.80%
ACUTA CAPITAL PARTNERS, LLC 400,000$4,296,0002.49%
BRIDGER MANAGEMENT, LLC 1,292,368$13,880,0000.95%
Rhenman & Partners Asset Management AB 200,000$2,148,0000.34%
KINGDON CAPITAL MANAGEMENT, L.L.C. 525,000$5,639,0000.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 400,000$4,296,0000.21%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$384,0000.19%
MASTERS CAPITAL MANAGEMENT LLC 500,000$5,370,0000.18%
Round Table Services, LLC 21,611$232,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders